Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H. Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine. 2019;37(21):2768–82. https://doi.org/10.1016/j.vaccine.2019.04.020.
Borrow R, Campbell H, Caugant DA, Cherkaoui A, Claus H, Deghmane AE, et al. Global meningococcal initiative: insights on antibiotic resistance, control strategies and advocacy efforts in Western Europe. J Infect. 2024;89(6):106335. https://doi.org/10.1016/j.jinf.2024.106335.
Harrison LH, Pelton SI, Wilder-Smith A, Holst J, Safadi MA, Vazquez JA, et al. The global meningococcal initiative: recommendations for reducing the global burden of meningococcal disease. Vaccine. 2011;29(18):3363–71. https://doi.org/10.1016/j.vaccine.2011.02.058.
Parikh SR, Campbell H, Bettinger JA, Harrison LH, Marshall HS, Martinon-Torres F, et al. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. 2020;81(4):483–98. https://doi.org/10.1016/j.jinf.2020.05.079.
Taha MK, Bekkat-Berkani R, Abitbol V. Changing patterns of invasive meningococcal disease and future immunization strategies. Hum Vaccin Immunother. 2023;19(1):2186111. https://doi.org/10.1080/21645515.2023.2186111.
Article PubMed PubMed Central Google Scholar
Borrow R, Findlow J. The important lessons lurking in the history of meningococcal epidemiology. Expert Rev Vaccines. 2024;23(1):445–62. https://doi.org/10.1080/14760584.2024.2329618.
Shin T, Wells CR, Shoukat A, Potter-Schwartz L, Langevin E, Langley JM, et al. Quadrivalent conjugate vaccine and invasive meningococcal disease in US adolescents and young adults. JAMA Netw Open. 2024;7(11):e2443551. https://doi.org/10.1001/jamanetworkopen.2024.43551.
Article PubMed PubMed Central Google Scholar
Guedes S, Bertrand-Gerentes I, Evans K, Coste F, Oster P. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature. BMC Public Health. 2022;22(1):380. https://doi.org/10.1186/s12889-022-12795-9.
Article PubMed PubMed Central Google Scholar
Weil-Olivier C, Taha MK, Leng S, Dinleyici EC, Bonanni P, Moya E, et al. Invasive meningococcal disease in older adults: current perspectives and call for action. Eur Geriatr Med. 2024;15(3):729–41. https://doi.org/10.1007/s41999-024-00969-0.
Article PubMed PubMed Central Google Scholar
du Parent Chatelet I, Deghmane AE, Antona D, Hong E, Fonteneau L, Taha MK, et al. Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015. J Infect. 2017;74(6):564–74. https://doi.org/10.1016/j.jinf.2017.02.011.
Santé Publique France. Les infections invasives à méningocoque en France en 2023. https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/infections-invasives-a-meningocoque/documents/bulletin-national2/infections-invasives-a-meningocoque-en-france-en-2023 Accessed 25 October 2024.
Olbrich KJ, Muller D, Schumacher S, Beck E, Meszaros K, Koerber F. Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers. Infect Dis Ther. 2018;7(4):421–38. https://doi.org/10.1007/s40121-018-0213-2.
Article PubMed PubMed Central Google Scholar
Huang L, Heuer OD, Janssen S, Hackl D, Schmedt N. Clinical and economic burden of invasive meningococcal disease: evidence from a large German claims database. PLoS ONE. 2020;15(1):e0228020. https://doi.org/10.1371/journal.pone.0228020.
Article PubMed PubMed Central Google Scholar
Weil-Olivier C, Taha MK, Bouee S, Emery C, Loncle-Provot V, Nachbaur G, et al. Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database. Hum Vaccin Immunother. 2022;18(1):e2021764. https://doi.org/10.1080/21645515.2021.2021764.
Weil-Olivier C, Taha MK, Emery C, Bouee S, Beck E, Aris E, et al. Healthcare resource consumption and cost of invasive meningococcal disease in France: a study of the National Health Insurance Database. Infect Dis Ther. 2021;10(3):1607–23. https://doi.org/10.1007/s40121-021-00468-w.
Article PubMed PubMed Central Google Scholar
Covinsky KE, Palmer RM, Fortinsky RH, Counsell SR, Stewart AL, Kresevic D, et al. Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J Am Geriatr Soc. 2003;51(4):451–8. https://doi.org/10.1046/j.1532-5415.2003.51152.x.
Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30(2):B3-9. https://doi.org/10.1016/j.vaccine.2011.12.062.
Campbell H, Andrews N, Parikh S, Ribeiro S, Gray S, Lucidarme J, et al. Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England. J Infect. 2020;80(2):182–9. https://doi.org/10.1016/j.jinf.2019.11.001.
Deghmane AE, Taha S, Taha MK. Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review. Infect Dis. 2022;54(1):1–7. https://doi.org/10.1080/23744235.2021.1971289.
Bertrand-Gerentes I, Fanchon L, Coste F, Glover RE, Guiddir T, Taha MK. Range of clinical manifestations caused by invasive meningococcal disease due to serogroup W: a systematic review. Infect Dis Ther. 2023;12(10):2337–51. https://doi.org/10.1007/s40121-023-00869-z.
Article PubMed PubMed Central Google Scholar
Vienne P, Ducos-Galand M, Guiyoule A, Pires R, Giorgini D, Taha MK, et al. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis. 2003;37(12):1639–42. https://doi.org/10.1086/379719.
Vossen M, Mitteregger D, Steininger C. Meningococcal pneumonia. Vaccine. 2016;34(37):4364–70. https://doi.org/10.1016/j.vaccine.2016.07.013.
Feldman C, Anderson R. Meningococcal pneumonia: a review. Pneumonia. 2019;11:3. https://doi.org/10.1186/s41479-019-0062-0.
Article PubMed PubMed Central Google Scholar
Hirai J, Kinjo T, Tome T, Hagihara M, Sakanashi D, Nakamura H, et al. Meningococcal pneumonia in Japan: a case report and literature review. J Infect Chemother. 2016;22(12):833–6. https://doi.org/10.1016/j.jiac.2016.07.014.
Sall O, Stenmark B, Jacobsson S, Eriksson L, Thulin Hedberg S, Hertting O, et al. Atypical presentation of Neisseria meningitidis serogroup W disease is associated with the introduction of the 2013 strain. Epidemiol Infect. 2021;149:e126. https://doi.org/10.1017/S0950268821001035.
Article PubMed PubMed Central Google Scholar
Stinson C, Burman C, Presa J, Abalos M. Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci. Epidemiol Infect. 2020;148:e12. https://doi.org/10.1017/S0950268819002152.
Article PubMed PubMed Central Google Scholar
Guiddir T, Gros M, Hong E, Terrade A, Denizon M, Deghmane AE, et al. Unusual initial abdominal presentations of invasive meningococcal disease. Clin Infect Dis. 2018;67(8):1220–7. https://doi.org/10.1093/cid/ciy257.
Deghmane AE, Taha S, Taha MK. Not only meningitis but also epiglottitis: an emerging clinical presentation of invasive meningococcal disease. Open Forum Infect Dis. 2024;11(1):ofad615. https://doi.org/10.1093/ofid/ofad615.
Ladhani SN, Lucidarme J, Parikh SR, Campbell H, Borrow R, Ramsay ME. Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis. Lancet. 2020;395(10240):1865–77. https://doi.org/10.1016/S0140-6736(20)30913-2.
Oliver SE, Retchless AC, Blain AE, McNamara LA, Ahrabifard S, Farley M, et al. Risk factors for invasive meningococcal disease belonging to a novel urethritis clade of Neisseria meningitidis-United States, 2013-2017. Open Forum Infect Dis. 2022;9(4):ofac035. https://doi.org/10.1093/ofid/ofac035.
Comments (0)